E Eftekharpour retweeted
Heart disease is the second leading cause of death in Canada, and people who work shifts may face a greater risk than most. Read more about Dr. Lorrie Kirshenbaum's groundbreaking research in the Wpg Free Press: bit.ly/4kCIP4G
E Eftekharpour retweeted
This is a fantastic opportunity for students and postdoctoral fellows who work on multiple sclerosis @endMS @MSCanOfficial
Please share! We've launched the 2025-2026 #endMS_SPRINT & 2025 #endMS_SummerSchool competitions! Inviting graduate students, post doctoral and clinical fellows, in MS research, to apply by Feb 19, 2025. For complete details: endmstrainingprogram.ca
@ChristinaWolfs1 @MSCanada
E Eftekharpour retweeted
I had this exact discussion with a student today - there’s so much to consider regarding how you take notes, whether by handwriting or typing. I experience this myself: when I handwrite, my ideas flow naturally, but when I type, I often feel stuck.
E Eftekharpour retweeted
The Dept. of Biological Sciences @Columbia is searching for an #AssistantProfessor in #biochemistry. (biochemical/biophysical approaches studying protein/nucleic acid function and dynamics, metabolism, microbial biology, or cancer biology) Please include a 1-page anonymized statement of research for the first round of review. Apply here: apply.interfolio.com/160181
E Eftekharpour retweeted
Congratulations @um_pharmacology faculty, Dr. Henry Dunn (@GPCRHenry), on their Brain Canada Future Leaders Grant!
With the help of a Lotte & John Hecht Memorial Foundation Future Leaders grant, Dr. @GPCRHenry is investigating a mutated gene that causes a defect at neuronal synapses in order to reveal new therapy options for patients with neurodevelopmental diseases. #FutureLeaderFriday
E Eftekharpour retweeted
We’re recruiting! Please distribute this to colleagues looking for a research-intensive academic position.
Dr. Dunn @GPCRHenry , once a student presenter at the U of M hosted Canadian Student Health Research forum (2012), described his amazing journey in becoming a promissing researcher in the field of GPCR.
E Eftekharpour retweeted
MSHRF Awards Ceremony #Post1
E Eftekharpour retweeted
MSHRF Day 2 - The Registration desk is moved to J. Hildes Concourse, BMSB- 2nd floor.
Largest poster competition event ever @MSHRF_UM. 183 posters presented and 32 judges made it possible! Including @GPCRHenry @KarimiLab @MB_MRI @LindseyLabGroup @PascoeCD @robin_dasilva @PCMarcogliese @DrPeterThompson @DrBradDoble @CellAutophagy @RabinovichInna @pauls_samantha
E Eftekharpour retweeted
A big shoutout to our Day 1 volunteers at the MSHRF @UM_RadyFHS Faculty of Health Sciences, University of Manitoba
E Eftekharpour retweeted
An amazing session by Lived Experience Panel #2024endMSSummerSchool in Winnipeg. It was well-received by trainees and enhanced the event. Grateful to @BarbMSWalkWpg and the entire panel for sharing their experience and Mona Bates from @MSCanOfficial for moderating the session.
Lived Experience Panel with @KarimiLab at End MS Summer School @MSCanOfficial
Manitoba’s biggest Research day EVER @MSHRF_UM is set to start on June 17th, 2024. More than 180 posters from PDFs, Graduate Students and selected Undergraduates will present their work. @um_research @umanitoba
Join us from June 17 to June 19, 2024 at the Manitoba Student Health Research Forum.
Registrations close on June 3, 2024.
Register at: docs.google.com/forms/d/e/1F…
E Eftekharpour retweeted
Join us from June 17 to June 19, 2024 at the Manitoba Student Health Research Forum.
Registrations close on June 3, 2024.
Register at: docs.google.com/forms/d/e/1F…
E Eftekharpour retweeted
It was great to share the cumulative knowledge on neural stem cell-mediated regeneration in multiple sclerosis and our advances in this field. Thank you for the invite @endMS @MSCanOfficial #endMS #RegenMed
The first session of the 2024 #endMS_SummerSchool (MS Pathogenesis, Prognosis, & Repair) in Winnipeg is off to a great start! Exciting presentations on neural stem cells and remyelination in MS from @AMVoronova and @KarimiLab






































